3. Addressing Challenging Transfer Pricing Items which Arose from BEPS - Enrique Rayon

14.05.2018 Views

Value Chain Analysis • The arm’s length principle and value creation, not formulary apportionment • Value Creation ≠ Value Chain Analysis • Selected countries require a value chain analysis is to be included in transfer pricing documentation, e.g., CN, NL, etc. • How and where is value created in the company? • VCA ≈ Art+Science • Delineate the intercompany transaction • Functional analysis (functions, risks, assets) • Economic Value of functions/risks/assets, again, not a formulary profit allocation Transfer Pricing | 2017

Value Chain Analysis Conventional Supply Chain Manufacturing Co. (Country A) Distribution Co. (Country B) Customers : Sales of Products Transfer Pricing | 2017

Value Chain Analysis<br />

Conventional Supply Chain<br />

Manufacturing<br />

Co.<br />

(Country A)<br />

Distribution<br />

Co.<br />

(Country B)<br />

Customers<br />

: Sales of Products<br />

<strong>Transfer</strong> <strong>Pricing</strong> | 2017

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!